1161 (1161) Fair Value & Analysis

Consumer Cyclical · Market cap HK$749M

1 1161 1161 · HK

PriceHK$1.10

Fair ValueHK$2.63

Upside+139.1%

Quality69/100

Evidence: High Range HK$1.97 – HK$3.28

Fair value as of: Jul 2, 2026

From 23 valuation models · updated today

Share price −3.4% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.8016 – HK$1.18 · fair‑value band HK$1.97 – HK$3.28 · the HK$1.10 price screens below the HK$2.63 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1161 (1161) currently trades at HK$1.10, while our model-based Fair Value estimate is HK$2.63 — implying the stock looks roughly 139.1% undervalued today. We read business quality at 69/100 (solid quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 1161 generated revenue of HK$1.0B at a net margin of 9.6%. Revenue grew 4.8% year over year. It earns a return on equity of 25.3%. The balance sheet holds a net cash position of HK$576M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$1.0B

Revenue growth (YoY) +4.8%

Net margin 9.6%

Return on equity 25.3%

Free cash flow HK$388M FY2025

P/E ratio 7.9

More key figures

Operating margin 17.4%

EPS (TTM) HK$0.0400

Dividend yield 6.9%

EPS growth (YoY) +27.1%

Net cash HK$576M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1161 reported revenue of HK$981M in FY2025 versus HK$830M in FY2021, a compound +4.3%/yr. Reported net income was HK$81.3M in FY2025, compounding −16.9%/yr from FY2021.

Revenue +4.3%/yr

FY21 HK$830M

FY22 HK$842M

FY23 HK$977M

FY24 HK$983M

FY25 HK$981M

Net income −16.9%/yr

FY21 HK$170M

FY22 HK$67.4M

FY23 HK$110M

FY24 HK$68.3M

FY25 HK$81.3M

Is 1161 fairly valued? → Check now

Similar stocks

6 more Personal Services stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Rollins, Inc ROL	$44.41	$21.11	-52%
Service Corporation SCI	$69.68	$23.62	-66%
H&R Block, Inc HRB	$38.58	$53.89	+40%
Frontdoor, Inc FTDR	$63.21	$51.10	-19%
Bright Horizons Family Solutions Inc BFAM	$64.29	$67.14	+4%
Fu Shou Yuan International Group FSHUF	$0.3800	$0.4800	+26%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1161 (1161) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$2.63 versus a price of HK$1.10 — about +139% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1161?

Our model-based fair value for 1161 is HK$2.63 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$1.10.

What is the quality score of 1161?

1161 has a Quality Score of 69/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1161 (1161)?

1161 reported trailing-twelve-month revenue of about HK$1.0B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1161?

The net profit margin of 1161 is about 9.6%, meaning it keeps roughly 9.6% of revenue as net income. Based on the latest reported figures.

Does 1161 pay a dividend?

1161 currently shows a dividend yield of about 6.94% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.